Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
14.28B | 14.54B | 14.66B | 14.85B | 12.52B | 10.58B | Gross Profit |
5.04B | 5.34B | 5.67B | 5.79B | 5.14B | 4.36B | EBIT |
4.93B | 5.25B | 5.56B | 6.02B | 5.59B | 4.36B | EBITDA |
6.72B | 7.07B | 7.34B | 7.39B | 6.65B | 5.76B | Net Income Common Stockholders |
3.24B | 3.47B | 3.71B | 4.17B | 3.78B | 2.77B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.99B | 1.00B | 1.44B | 2.09B | 2.32B | 3.13B | Total Assets |
37.44B | 42.76B | 42.41B | 41.91B | 40.53B | 39.79B | Total Debt |
13.79B | 18.99B | 19.09B | 18.05B | 16.37B | 16.70B | Net Debt |
11.81B | 18.06B | 17.74B | 16.09B | 14.13B | 13.58B | Total Liabilities |
23.05B | 30.26B | 30.27B | 29.29B | 27.03B | 26.68B | Stockholders Equity |
14.39B | 12.50B | 12.13B | 12.63B | 13.50B | 13.11B |
Cash Flow | Free Cash Flow | ||||
2.69B | 2.72B | 3.27B | 3.49B | 3.31B | 2.64B | Operating Cash Flow |
5.42B | 5.25B | 5.55B | 5.62B | 5.10B | 4.26B | Investing Cash Flow |
-2.75B | -2.60B | -2.29B | -2.13B | -1.88B | -649.00M | Financing Cash Flow |
-3.01B | -3.06B | -3.87B | -3.77B | -4.11B | -1.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $55.67B | 16.86 | 24.52% | 2.19% | 0.70% | 135.08% | |
76 Outperform | $52.45B | 13.61 | 14.74% | 2.55% | 0.34% | -8.45% | |
73 Outperform | $59.63B | 18.91 | 26.13% | 1.57% | -2.39% | -7.80% | |
73 Outperform | $83.45B | 14.13 | 35.96% | 6.75% | 1.30% | -0.76% | |
67 Neutral | $13.90B | 25.26 | 13.97% | 1.25% | -3.82% | -12.80% | |
67 Neutral | $33.74B | 29.93 | 26.59% | 0.66% | -2.63% | -6.12% | |
66 Neutral | $4.48B | 12.26 | 5.32% | 248.53% | 4.10% | -12.36% |
On May 7, 2025, CSX Corporation held its Annual Meeting of Shareholders where twelve directors were elected to the board. Additionally, shareholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for 2025 and approved, on a non-binding basis, the compensation of CSX’s named executive officers.
The most recent analyst rating on (CSX) stock is a Buy with a $39.00 price target. To see the full list of analyst forecasts on CSX stock, see the CSX Stock Forecast page.